pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Methylphenidate Padagis
drug
save

methylphenidate ER

Marketedupdated 5mo ago
by Padagis LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval466 co-mentions · 233 sources
  • drugMETADATE CD378 co-mentions · 206 sources
  • drugMETADATE ER248 co-mentions · 206 sources
  • drugmethylphenidate238 co-mentions · 238 sources
  • drugRITALIN LA231 co-mentions · 206 sources
  • drugQuillivant XR220 co-mentions · 206 sources
  • drugMETHYLIN ER219 co-mentions · 206 sources
  • drugMethylin219 co-mentions · 206 sources

all catalysts(0)

nothing on the calendar yet

Trials studying methylphenidate ER

  • phase4Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With ADHD and Cannabis Use Disordernot yet recruitingn=66
  • phase3Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.completedn=26
  • phase4EEG Biomarkers for ADHD Stimulant Treatmentnot yet recruitingn=220
  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • phase1A Trial to Assess How Centanafadine Interacts With Stimulants in the Bodyrecruitingn=42
  • phase3Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301completedn=103
  • phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHDterminatedn=26
  • phase4A Safety/Tolerability and PK Study With Azstarys® in Children With ADHDcompletedn=123

News(0)

no news has mentioned this drug yet

brand
Methylphenidate Padagis
generic
methylphenidate
indication
Attention Deficit Hyperactivity Disorder (ADHD)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?